Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 43 - Drugs for specific purposes, not provided for in groups
Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
10/1991
10/17/1991WO1991015231A1 Wound healing
10/17/1991WO1991015227A1 Method and compositions for treating injury
10/17/1991WO1991015219A1 Method of treatment with hsp70
10/17/1991WO1991015208A1 Veterinary treatment
10/17/1991WO1991013062A3 Substituted 1-(alkoxy-iminoalkyl)imidazole derivatives
10/17/1991WO1991006537A3 Substituted indole-, indene-, pyranoindole- and tetrahydrocarbazole- alkanoic acid derivatives as inhibitors of pla2 and lipoxygenase
10/17/1991WO1991000916A3 Receptors for fibroblast growth factors
10/17/1991CA2080582A1 Heterocyclicethenediyl compounds which inhibit egf receptor tyrosine kinase
10/17/1991CA2079813A1 Method of treatment with hsp70
10/16/1991EP0452074A2 Ergoline-8-carboxamides for blocking 5HT receptors
10/16/1991EP0451880A2 An ex vivo tissue perfusion composition and the use thereof
10/16/1991EP0451834A2 Alpha-mannosidase and fucosidase inhibitors
10/16/1991EP0451824A2 Chelating compounds and their use
10/16/1991EP0451538A2 Use of pyridoindole derivatives in the treatment of ischemic disorders
10/16/1991EP0277151B1 Novel medicinal use of nucleosides
10/16/1991CN1055365A Haloethyl-substituted steroidal enzyme inhibitors
10/16/1991CN1055361A Substituted pyrrole, process for preparing same, preparation containing compounds, and use
10/15/1991US5057530 Glycerol derivatives
10/15/1991US5057516 Nervous system disorders
10/15/1991US5057494 Method for preventing tissue damage after an ischemic episode
10/15/1991US5057322 Method of treating mast cell disease
10/15/1991US5057319 Pharmaceutical compositions of cimetidine
10/15/1991CA1290756C Quinazolinone derivative and processes for preparing the same
10/15/1991CA1290753C Tetrapyrrole therapeutic agents
10/15/1991CA1290691C Methods of treating bone diseases by administration of a cysteine proteinase inhibitor
10/14/1991WO1991016313A1 Substituted benzimidazoles
10/14/1991CA2077897A1 Substituted benzimidazoles
10/12/1991CA2040170A1 Ergoline-8-carboxamides
10/11/1991WO1991015507A1 Phosphonopeptides with collagenase inhibiting activity
10/11/1991WO1991015506A1 Phosphonopeptides with collagenase inhibiting activity
10/11/1991CA2080228A1 Phosphonopeptides with collagenase inhibiting activity
10/11/1991CA2080227A1 Phosphonopeptides with collagenase inhibiting activity
10/10/1991WO1991015486A1 Thiophene sulfonamides useful as carbonic anydrase inhibitors
10/09/1991EP0451022A1 Novel compounds for the treatment of migraine
10/09/1991EP0450812A1 Antihypercholesterolemics
10/09/1991EP0450757A2 Use of 5-hydroxytryptamine-antagonists in the treatment of mental disorders originating in childhood
10/09/1991EP0450660A1 Anti-atherosclerotic diaryl compound
10/09/1991EP0450566A1 Substituted azoles, method for their preparation, these containing compositions and their use
10/09/1991EP0450559A1 3-hydroxy derivates of mevinic acid
10/09/1991EP0450515A2 Haloethyl-substituted steroidal enzyme inhibitors
10/09/1991EP0450398A2 Chondroitin sulfate complexes having anti-inflammatory activity, processes for the preparation thereof and pharmaceutical compositions containing them
10/09/1991EP0450238A1 Novel compounds for the treatment of migraine
10/09/1991EP0450066A1 Carbostyril derivatives
10/09/1991EP0450040A1 Pharmaceutical and cosmetic depigmentation compositions with a caffeic acid base
10/09/1991EP0449973A1 Polypeptide-polymer conjugates active in wound healing.
10/09/1991CN1055182A N-(pyrrolo (2,3-d) pyrimidin-3-ylacyl)-glutamic acid derivatives
10/09/1991CN1055181A Selective adenosine receptor agents
10/09/1991CN1055175A Benzocycloalkenecarboxylic acid and process for its prepn.
10/09/1991CN1055172A Di-and tetra-fluoro analogs of squalene as inhibitors of squalene epoxidase
10/08/1991US5055613 Metabolites of pentanedioic acid derivatives
10/08/1991US5055598 Benzopyran derivatives
10/08/1991US5055591 Process for the preparation of octahydropenta(b)pyrrole carboxylates
10/08/1991US5055480 Topically active ocular gem-diacylthiadiazole sulfonamide carbonic anhydrase inhibitors
10/08/1991US5055472 Pyrazolopyrimidine type mevalonolactones
10/08/1991US5055451 Prevent tissue damage
10/07/1991WO1991015483A1 An improved process for the preparation of substituted isoflavone derivatives
10/06/1991WO1991015451A1 Novel derivatives of phenyl-cycloalkanes and -cycloalkenes
10/06/1991CA2079785A1 Derivatives of phenyl-cycloalkanes and cycloalkenes
10/05/1991WO1991015229A1 Modified heparin binding growth factors
10/05/1991WO1991015222A2 Method of predisposing mammals to accelerated tissue repair
10/05/1991CA2079604A1 Modified heparin binding growth factors
10/05/1991CA2078547A1 Method of predisposing mammals to accelerated tissue repair
10/05/1991CA2039622A1 Substituted azoles, processes for the preparation thereof, agents containing these, and the use thereof
10/04/1991CA2037877A1 6-alpha hydroxy derivatives of mevinic acids
10/03/1991WO1991015495A1 Benzylphosphonic acid tyrosine kinase inhibitors
10/03/1991WO1991014785A1 High level expression of basic fibroblast growth factor having a homogeneous n-terminus
10/03/1991WO1991014686A1 Azacyclic or azabicyclic compounds, their preparation and use
10/03/1991WO1991014443A1 A method for regulating neuron development and maintenance
10/03/1991WO1991014367A1 Treatment of central nervous system disorders with imidazole angiotensin-ii receptor antagonists
10/03/1991WO1991011462A3 Merosin, nucleic acids encoding, fragments and uses thereof
10/03/1991CA2078791A1 Azacyclic or azabicyclic compounds, their preparation and use
10/03/1991CA2039458A1 Methods for treating interleukin-1 mediated diseases
10/02/1991EP0449764A2 A method of reducing serum uric acid and/or increasing renal uric acid clearance with thromboxane synthetase inhibitor and/or thromboxane receptor antagonist
10/02/1991EP0449562A2 Use of R-Fluoxetine as selective serotonin IC-receptor ligands
10/02/1991EP0449561A2 Use of (R)-norfluoxetine in the preparation of a medicament with affinity to 5HT1c receptors
10/02/1991EP0449523A1 Mercapto- or acylthio-trifluoromethyl amide derivatives and their use
10/02/1991EP0449211A1 3,5-ditertiarybutyl-4-hydroxyphenyl, 1,3,4-thiadiazoles and oxadiazoles linked by carbon, oxygen, and sulfur residues
10/02/1991EP0449175A2 Selective adenosine receptor agents
10/02/1991EP0448934A2 Di- and tetra-fluoro analogs of squalene as inhibitors of squalene epoxidase
10/02/1991EP0448765A1 Use of guanidine derivatives for the manufacture of a medicament with NPY-antagonistic activity
10/02/1991EP0448704A1 Osteogenic devices
10/02/1991EP0448637A1 Heparin fragments as inhibitors of smooth muscle cell profileration
10/02/1991EP0393140A4 Topical wound-healing preparations comprising interleukin-1 proteins
10/01/1991US5053548 Biphenyl derivative composition for nerve cell degeneration repairing or protective agent and process for preparing a phenyl derivative contained in the composition
10/01/1991US5053547 Benzonorbornene derivatives, processes for their preparation and medicinal and cosmetic compositions containing them
10/01/1991US5053419 Administering calcium channel antagonists
10/01/1991US5053400 Anticoagulants; hypotensive agents; bronchodilator agents; tissue specificity
10/01/1991US5053398 Sulfated homopolysaccharides as anti-aids virus agents
10/01/1991CA2039320A1 Biogenic amine uptake inhibitors
10/01/1991CA2037433A1 Use of guanidine derivatives for the preparation of a pharmaceutical product having pny antagonistic activity
10/01/1991CA1290097C Peptide enzyme inhibitors
10/01/1991CA1289955C Synthesis of 2-aminopyrimido¬4,5-g|quinolines
10/01/1991CA1289887C Composition containing gamma-linolenic acid and calcium
10/01/1991CA1289882C Method and compositions comprising a vitamin d derivative for the local treatment of bone fractures
10/01/1991CA1289878C Composition for stimulating chondrocytes and osteoblasts (osseinhydroxyapatite compound), method for its production and pharmaceutical products containing said composition
09/1991
09/30/1991CA2039103A1 Improvements in and relating to the selective occupation of serotonin 1c receptors
09/30/1991CA2039102A1 Compounds affecting serotonin receptors
09/28/1991WO1991014674A2 5-lipoxygenase inhibitors
09/28/1991WO1991014671A1 New benzocycloalkene carboxylic acid and process for producing it
09/28/1991CA2078126A1 5-lipoxygenase inhibitors
1 ... 1480 1481 1482 1483 1484 1485 1486 1487 1488 1489 1490 1491 1492 1493 1494 1495 1496 1497 1498 1499 1500 ... 1564